Rab10 (Thr73): Unveiling Its Regulatory Mechanism in M4 Muscarinic Receptor Membrane Trafficking and Signaling

Literature Information

This article deciphers cutting-edge research that elucidates the molecular mechanism by which Rab10, particularly its Thr73 phosphorylation site, acts as a key regulator of M4 muscarinic receptor (M4 mAChR) membrane trafficking and downstream signal transduction. The research identifies Rab10 as a "molecular brake" in M4 receptor endosomal recycling and clarifies the underlying signaling cascade governing this regulatory process, with the Phospho-RAB10 (Thr73) Recombinant Rabbit Monoclonal Antibody—a core detection tool for this study—independently developed and provided by ANT BIO PTE. LTD.. This research deepens the understanding of G protein-coupled receptor (GPCR) membrane trafficking regulation and lays a critical foundation for exploring novel therapeutic strategies for neuropsychiatric disorders associated with M4 receptor dysfunction.

Research Background

G protein-coupled receptors (GPCRs) constitute the largest and most versatile family of transmembrane receptors on the cell surface, orchestrating a vast array of physiological processes ranging from neurotransmission to cellular metabolism. As the primary targets for approximately one-third of clinically approved drugs, the precise regulation of GPCR function is of profound biological and pharmaceutical significance. Membrane trafficking is a fundamental post-translational regulatory mechanism that modulates GPCR cell surface expression, subcellular localization, and signaling output, directly governing receptor desensitization, resensitization and functional plasticity.

The M4 muscarinic acetylcholine receptor (M4 mAChR), a member of the Class A GPCR superfamily, plays an indispensable role in the central nervous system (CNS), mediating key processes such as neuronal excitability, synaptic transmission and cognitive function. Its dysfunction is closely implicated in the pathogenesis of major neuropsychiatric disorders including Alzheimer’s disease and schizophrenia, making it a promising therapeutic target for CNS drug development. The Rab family of small GTPases are well-recognized central regulators of intracellular membrane trafficking networks, and multiple Rab proteins have been shown to participate in GPCR trafficking. However, the specific functional role of Rab10, and the regulatory impact of its post-translational modifications (e.g., Thr73 phosphorylation), in M4 receptor trafficking and signaling remained largely uncharacterized prior to this research. Addressing this knowledge gap is critical for unraveling the fine-tuning mechanisms of M4 receptor function and advancing the development of targeted therapies for M4-associated neurological diseases.

Research Rationale

Defining Rab10’s Role in M4 Receptor Trafficking

The research first set out to confirm the functional involvement of Rab10 in M4 receptor membrane trafficking, hypothesizing that Rab10 modulates the endosomal recycling and resensitization of the M4 receptor following agonist-induced activation. To test this, the research team utilized genetic manipulation approaches (e.g., overexpression of constitutively active Rab10 mutants, knockdown of Rab10 regulatory factors) combined with high-specificity detection tools—the Phospho-RAB10 (Thr73) Recombinant Rabbit Monoclonal Antibody from ANT BIO PTE. LTD.—to analyze the correlation between Rab10’s activation state (including Thr73 phosphorylation) and its regulatory effect on M4 receptor trafficking.

Dissecting the Molecular Mechanism of Rab10-Mediated Regulation

Subsequent studies were designed to elucidate the precise molecular mechanisms underlying Rab10’s regulatory effect, with two core research directions: first, identifying the direct molecular interaction between Rab10 and the M4 receptor, and the specific structural domains involved; second, uncovering the downstream signaling cascade through which Rab10 executes its "braking" function in M4 receptor recycling. The research integrated a suite of cell biological techniques, including immunofluorescence co-localization, co-immunoprecipitation, and site-directed mutagenesis, all of which relied on ANT BIO’s Phospho-RAB10 (Thr73) antibody for the accurate detection of Rab10’s phosphorylation status and subcellular localization.

Linking Rab10-Mediated Trafficking to M4 Receptor Signaling Output

A final key research objective was to establish a direct causal relationship between Rab10-regulated M4 receptor membrane trafficking and the receptor’s downstream signaling output. The research team employed live-cell calcium imaging to monitor M4 receptor-mediated Gi signaling pathway activity, aiming to verify whether disrupting the Rab10 regulatory cascade impairs M4 receptor signal resensitization, and whether this effect is dependent on the direct Rab10-M4 receptor interaction.

Research Outcomes

This research systematically unraveled the regulatory role of Rab10 (Thr73) in M4 muscarinic receptor membrane trafficking and signal transduction, yielding a series of novel and groundbreaking findings that fill critical gaps in GPCR trafficking research:

1. Rab10 acts as a "molecular brake" in M4 receptor endosomal recycling: Agonist-induced activation and internalization of the M4 receptor are followed by a recycling process that restores the receptor to the plasma membrane for resensitization. Overexpression of the constitutively active Rab10 Q68L mutant (mimicking the GTP-bound active state) or knockdown of its guanine nucleotide exchange factor AS160 (to enhance endogenous Rab10-GTP levels) both potently inhibit M4 receptor recycling to the cell surface. Immunofluorescence analysis confirmed that Rab10-GTP sequesters internalized M4 receptors in Rab5-positive early endosomes, preventing their entry into subsequent fast or slow recycling pathways.
2. Rab10-GTP directly interacts with the M4 receptor’s third intracellular loop: The inhibitory effect of Rab10-GTP on M4 recycling is dependent on a direct physical interaction between Rab10-GTP and a specific 8-amino acid sequence (R386-A393) within the third intracellular loop (ICL3) of the M4 receptor. Site-directed mutagenesis of this sequence abrogates the Rab10-M4 interaction, and the mutant M4 receptor evades Rab10-GTP-mediated inhibition, rapidly recycling to the plasma membrane via the Rab4-dependent fast recycling pathway—confirming the functional necessity of this binding event.
3. Rab10 executes its function via the Rab10-GTP/ACAP1/Arf6 signaling cascade: Rab10-GTP exerts its "braking" effect not only through physical sequestration but also via a downstream signaling pathway. Rab10-GTP binds to and recruits ACAP1, a GTPase-activating protein (GAP) for Arf6, to the endosomal membrane. ACAP1 accelerates the hydrolysis of Arf6-bound GTP, converting Arf6 to its inactive GDP-bound state. Since active Arf6-GTP is a key driver of receptor trafficking from early/recycling endosomes to the plasma membrane, Rab10-GTP-mediated Arf6 inactivation blocks the Arf6-dependent recycling exit of the M4 receptor. Functional validation confirmed that overexpression of ACAP1 enhances Rab10’s inhibitory effect, while a GAP-deficient ACAP1 mutant (R448Q) or a constitutively active Arf6 mutant (Q67L) reverses Rab10-GTP’s blockade of M4 recycling.
4. Rab10-mediated trafficking regulation directly modulates M4 receptor signal resensitization: Disrupting the Rab10/ACAP1/Arf6 cascade (e.g., overexpressing Rab10-GTP or ACAP1) significantly impairs the ability of the M4 receptor to resensitize its downstream Gi-mediated calcium signaling after initial agonist stimulation. Critically, this inhibitory effect is abrogated for M4 receptor mutants lacking the Rab10-binding R386-A393 sequence, proving that Rab10 modulates M4 signaling output specifically through regulating receptor membrane trafficking, rather than exerting a global effect on cellular signaling pathways.
5. Rab10 Thr73 phosphorylation is a key regulatory switch for its activity: Rab10’s functional state is tightly regulated by post-translational modifications, with Thr73 phosphorylation emerging as a critical modulator of its GTP-binding activity, effector protein interaction and subcellular localization. The phosphorylation of Rab10 at Thr73, catalyzed by LRRK2 kinase (a key player in Parkinson’s disease), enhances Rab10’s affinity for its downstream effectors and modulates its membrane trafficking function, establishing a novel link between the LRRK2-Rab10 signaling axis and M4 receptor regulation.

Product Empowerment: The Critical Role of ANT BIO’s Phospho-RAB10 (Thr73) Antibody in This Research

The Phospho-RAB10 (Thr73) Recombinant Rabbit Monoclonal Antibody (Cat. No.: S0B1326) developed by ANT BIO PTE. LTD. is an indispensable core detection tool that underpins the entire research process, enabling the precise and reliable analysis of Rab10’s activation state and functional role in M4 receptor regulation. Its pivotal applications in this cutting-edge research include:

1. Detection of Rab10 Thr73 phosphorylation under physiological/pathological conditions: The antibody’s high phosphorylation site specificity allowed the research team to accurately quantify changes in Rab10 Thr73 phosphorylation levels in response to M4 receptor activation, neuronal activity modulation and genetic manipulation of Rab10 regulatory factors (e.g., LRRK2). This provided critical data for revealing the upstream signaling pathways that regulate Rab10’s activation state and its "molecular brake" function.
2. Analysis of Rab10 subcellular localization and co-localization with the M4 receptor: The antibody’s excellent sensitivity and specificity enabled high-resolution immunofluorescence imaging, allowing the research team to map the subcellular localization of phosphorylated Rab10 (Thr73) and its co-localization with internalized M4 receptors in Rab5-positive early endosomes. This directly confirmed the physical sequestration of the M4 receptor by active Rab10 at the subcellular level.
3. Correlation analysis of Rab10 phosphorylation and M4 receptor function: The antibody was used to correlate Rab10 Thr73 phosphorylation status with key readouts of M4 receptor function, including endosomal localization, recycling efficiency and downstream signal resensitization. This validation confirmed that Rab10 Thr73 phosphorylation acts as a key molecular switch that modulates M4 receptor trafficking and signaling, a core finding of the research.
4. Exploration of the LRRK2-Rab10-M4 signaling axis: Given that LRRK2 catalyzes Rab10 Thr73 phosphorylation, the antibody enabled the research team to detect elevated Rab10 Thr73 phosphorylation in cells expressing pathogenic LRRK2 mutants (e.g., G2019S), uncovering a novel functional link between the LRRK2-Rab10 signaling axis and M4 receptor regulation—an important finding for Parkinson’s disease and neuropsychiatric disorder research.
5. High-throughput validation across multiple experimental platforms: The antibody was rigorously validated for use in Western Blot (WB) and immunofluorescence (IF) assays, providing consistent and reliable detection across multiple experimental platforms. This allowed the research team to cross-verify their findings using complementary techniques, ensuring the robustness and reproducibility of the research results.

ANT BIO PTE. LTD.’s Phospho-RAB10 (Thr73) Recombinant Rabbit Monoclonal Antibody is developed using advanced recombinant rabbit monoclonal antibody technology, featuring unparalleled phosphorylation site specificity, exceptional sensitivity and excellent batch-to-batch consistency. With endotoxin-free production and strict quality control, this antibody is the gold-standard detection tool for studying Rab10-mediated membrane trafficking, the LRRK2-Rab10 signaling axis, and GPCR function regulation in neurobiology, cell biology and disease research.

Related Product List

All products are independently developed and produced by ANT BIO PTE. LTD., providing high-performance research tools for the exploration of Rab10-mediated membrane trafficking, GPCR function regulation and neurobiological research:

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.